Article
Utilization of next generation sequencing from glioma patient liquid biopsy to determine survival prognostics: A systematic review.
Research record from Gene, 2026-03-13. PMID 41833802.
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Article
Research record from Gene, 2026-03-13. PMID 41833802.
Technology
A technique designed to rapidly enrich and amplify targets derived from samples that yield low levels of nucleic acids, such as formalin-fixed paraffin-embedded (FFPE) tissues, for use in next-generation sequencing. Briefly, total nucleic acid or genomic DNA (gDNA) is isolated from fresh or FFPE tissues. Total nucleic acid is converted to double-stranded cDNA (dscDNA) and cleaned by solid-phase reversible immobilization (SPRI). Then the dscDNA or gDNA is subjected to end repair, adenylation and ligation with a universal half-functional adapter. The modified DNA sample is then subjected to two rounds of nested low-cycle PCR, where the first round uses target gene-specific primers and the second round uses nested target gene-specific primers that are 5' tagged with a common sequencing adapter. The resulting target amplicon library is cleaned using SPRI and is suitable for use in next generation genomic assays.
Technology
A DNA sequencing technique that can differentiate cytosine from 5-methylcytosine in a DNA sample. First, a denatured DNA sample is treated with bisulfite which converts non-methylated cytosine to uracil. Next, the sample is amplified using a PCR method that does not discriminate between non-methylated and methylated sequences. The amplified DNA is subjected to nucleotide sequencing. The resulting sequence is compared to an identical control sample of DNA that was not treated with bisulfite. Unmethylated cytosines will be displayed as cytosines in the control sample and as thymines in the bisulfite-treated sample.
Technology
A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations.
Technology
A proprietary next-generation DNA sequencing technology from Oxford Nanopore Technologies that can directly identify and sequence a DNA molecule as it passes through a nanopore, driven by electrophoresis.
Technology
A technique that determines the nucleotide sequence of a pre-specified region of DNA or RNA by using primers that are specific for that region.
Technology
Match sample types with extraction, assay and workflow considerations for practical PCR planning.
Article
Research record from Pathology, 2026-03-06. PMID 41956934.
Article
Research record from Zhonghua Zhong Liu Za Zhi, 2026-07-01. PMID 42477931.
Article
Research record from Zhonghua Er Ke Za Zhi, 2026-03-14. PMID 41834204.
Article
Research record from Zhongguo Dang Dai Er Ke Za Zhi, 2026-07-01. PMID 42457325.
Article
Research record from Zhejiang Da Xue Xue Bao Yi Xue Ban, 2026-06-08. PMID 42811263.